The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Lomitapide and Mipomersen: Two First-in-Class Drugs for Reducing Low-Density Lipoprotein Cholesterol in Patients With Homozygous Familial Hypercholesterolemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial
Huijgen, R., Boekholdt, S. M., Arsenault, B. J., Bao, W., Davaine, J., Tabet, F., Petrides, F., Rye, K., DeMicco, D. A., Barter, P. J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.043 · Cited by 56
Self-citationRetractedThe metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia
Wetterau, J. R., Aggerbeck, L. P., Bouma, M.-E., Eisenberg, C., Munck, A., Hermier, M., Schmitz, J., Gay, G., Rader, D. J., & Gregg, R. E. (1992) · Science · doi:10.1126/science.1439810 · Cited by 762
Self-citationCuchel, M., Meagher, E. A., du Toit Theron, H., Blom, D. J., Marais, A. D., Hegele, R. A., Averna, M. R., Sirtori, C. R., Shah, P. K., Gaudet, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61731-0 · Cited by 744
Self-citationSniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Cuchel, M., Bloedon, L. T., Szapary, P. O., Kolansky, D. M., Wolfe, M. L., Sarkis, A., Millar, J. S., Ikewaki, K., Siegelman, E. S., Gregg, R. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061189 · Cited by 580
Self-citationMonogenic hypercholesterolemia: new insights in pathogenesis and treatment
Rader, D. J., Cohen, J., & Hobbs, H. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18925 · Cited by 560
Self-citationGagné, C., Gaudet, D., & Bruckert, E. (2002) · Circulation · doi:10.1161/01.cir.0000018744.58460.62 · Cited by 482
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Sharp, D., Blinderman, L., Combs, K. A., Kienzle, B., Ricci, B., Wager-Smith, K., Gil, C. M., Turck, C. W., Boumas, M.-E., Rader, D. J., et al. (1993) · Nature · doi:10.1038/365065a0 · Cited by 393
Self-citationRaal, F. J., Pilcher, G. J., Panz, V. R., van Deventer, H. E., Brice, B. C., Blom, D. J., & Marais, A. D. (2011) · Circulation · doi:10.1161/circulationaha.111.042523 · Cited by 366
Kastelein, J. J. P., Wedel, M. K., Baker, B. F., Su, J., Bradley, J. D., Yu, R. Z., Chuang, E., Graham, M. J., & Crooke, R. M. (2006) · Circulation · doi:10.1161/circulationaha.105.606442 · Cited by 358
Self-citationDetermination of the Role of the Human RNase H1 in the Pharmacology of DNA-like Antisense Drugs
Wu, H., Lima, W. F., Zhang, H., Fan, A., Sun, H., & Crooke, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311683200 · Cited by 349
PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease
Benn, M., Nordestgaard, B. G., Grande, P., Schnohr, P., & Tybjærg-Hansen, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.044 · Cited by 314
The Role of the Microsomal Triglygeride Transfer Protein in Abetalipoproteinemia
Berriot-Varoqueaux, N., Aggerbeck, L. P., Samson-Bouma, M.-E., & Wetterau, J. R. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.663 · Cited by 312
Stein, E. A., Dufour, R., Gagne, C., Gaudet, D., East, C., Donovan, J. M., Chin, W., Tribble, D. L., & McGowan, M. (2012) · Circulation · doi:10.1161/circulationaha.112.104125 · Cited by 301
Stein, E. A., Honarpour, N., Wasserman, S. M., Xu, F., Scott, R., & Raal, F. J. (2013) · Circulation · doi:10.1161/circulationaha.113.004678 · Cited by 300
Antisense oligonucleotide pharmacokinetics and metabolism
Geary, R. S. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902877680 · Cited by 300
An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
Wetterau, J. R., Gregg, R. E., Harrity, T. W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.-H., George, R. J., Gordon, D. A., Jamil, H., et al. (1998) · Science · doi:10.1126/science.282.5389.751 · Cited by 267
Multiple functions of microsomal triglyceride transfer protein
Hussain, M. M., Rava, P., Walsh, M., Rana, M., & Iqbal, J. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-14 · Cited by 261
Familial hypobetalipoproteinemia.
Linton, M., Farese, R., & Young, S. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39976-4 · Cited by 257
Thomas, G. S., Cromwell, W. C., Ali, S., Chin, W., Flaim, J. D., & Davidson, M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.081 · Cited by 245
Yu, R. Z., Kim, T.-W., Hong, A., Watanabe, T. A., Gaus, H. J., & Geary, R. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012401 · Cited by 244
Crooke, R. M., Graham, M. J., Lemonidis, K. M., Whipple, C. P., Koo, S., & Perera, R. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400492-jlr200 · Cited by 225
McGowan, M. P., Tardif, J.-C., Ceska, R., Burgess, L. J., Soran, H., Gouni-Berthold, I., Wagener, G., & Chasan-Taber, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049006 · Cited by 224
Samaha, F. F., McKenney, J., Bloedon, L. T., Sasiela, W. J., & Rader, D. J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1250 · Cited by 220
Self-citationMetabolic Effects of Alcohol on the Liver
Isselbacher, K. J., & Greenberger, N. J. (1964) · New England Journal of Medicine · doi:10.1056/nejm196402132700707 · Cited by 214
Visser, M. E., Wagener, G., Baker, B. F., Geary, R. S., Donovan, J. M., Beuers, U. H. W., Nederveen, A. J., Verheij, J., Trip, M. D., Basart, D. C. G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs023 · Cited by 192
Self-citationKolansky, D. M., Cuchel, M., Clark, B. J., Paridon, S., McCrindle, B. W., Wiegers, S. E., Araujo, L., Vohra, Y., Defesche, J. C., Wilson, J. M., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.035 · Cited by 181
Self-citationAntisense Drug Technology: Principles, Strategies, and Applications, Second Edition
(2007) · CRC Press eBooks · doi:10.1201/9780849387951 · Cited by 181
Akdim, F., Visser, M. E., Tribble, D. L., Baker, B. F., Stroes, E. S. G., Yu, R., Flaim, J. D., Su, J., Stein, E. A., & Kastelein, J. J. P. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.003 · Cited by 179
Self-citationChandler, C. E., Wilder, D. E., Pettini, J. L., Savoy, Y. E., Petras, S. F., Chang, G., Vincent, J., & Harwood, H. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300094-jlr200 · Cited by 177
Davis, R. A. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00083-9 · Cited by 176
Molecular diagnosis of hypobetalipoproteinemia: An ENID review
Tarugi, P., Averna, M., Di Leo, E., Cefalù, A. B., Noto, D., Magnolo, L., Cattin, L., Bertolini, S., & Calandra, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.003 · Cited by 175
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism
Ginsberg, H. N., & Fisher, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800090-jlr200 · Cited by 172
Linsel-Nitschke, P., Götz, A., Erdmann, J., Braenne, I., Braund, P., Hengstenberg, C., Stark, K., Fischer, M., Schreiber, S., El Mokhtari, N. E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002986 · Cited by 166
Akdim, F., Stroes, E. S. G., Sijbrands, E. J. G., Tribble, D. L., Trip, M. D., Jukema, J. W., Flaim, J. D., Su, J., Yu, R., Baker, B. F., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.069 · Cited by 162
Self-citationHepatic steatosis and insulin resistance: Does etiology make a difference?
Lonardo, A., Lombardini, S., Scaglioni, F., Carulli, L., Ricchi, M., Ganazzi, D., Adinolfi, L. E., Ruggiero, G., Carulli, N., & Loria, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.018 · Cited by 159
Familial hypobetalipoproteinemia: genetics and metabolism
Schonfeld, G., Lin, X., & Yue, P. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4473-0 · Cited by 159
Merki, E., Graham, M. J., Mullick, A. E., Miller, E. R., Crooke, R. M., Pitas, R. E., Witztum, J. L., & Tsimikas, S. (2008) · Circulation · doi:10.1161/circulationaha.108.786822 · Cited by 156
Jamil, H., Gordon, D. A., Eustice, D. C., Brooks, C. M., Dickson, J. K., Chen, Y., Ricci, B., Chu, C., Harrity, T. W., Ciosek, C. P., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11991 · Cited by 149
Amaro, A., Fabbrini, E., Kars, M., Yue, P., Schechtman, K. B., Schonfeld, G., & Klein, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.039 · Cited by 135
Liver Ultrastructure in Abetalipoproteinemia: Evolution of Micronodular Cirrhosis
Partin, J. S., Partin, J. C., Schubert, W. K., & McAdams, A. J. (1974) · Gastroenterology · doi:10.1016/s0016-5085(19)32931-2 · Cited by 131
Yu, R. Z., Lemonidis, K. M., Graham, M. J., Matson, J. E., Crooke, R. M., Tribble, D. L., Wedel, M. K., Levin, A. A., & Geary, R. S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.005 · Cited by 125
Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia
Akdim, F., Tribble, D. L., Flaim, J., Yu, R. Z., Su, J. Q., Geary, R. S., Baker, B. F., Fuhr, R., Wedel, M. K., & Kastelein, J. J. P. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr148 · Cited by 123
Self-citationSevere Hypertriglyceridemia With Pancreatitis
Sacks, F. M., Stanesa, M., & Hegele, R. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13309 · Cited by 119
Liao, W., Hui, T. Y., Young, S. G., & Davis, R. A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300020-jlr200 · Cited by 117
Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia
Sankatsing, R. R., Fouchier, S. W., de Haan, S., Hutten, B. A., de Groot, E., Kastelein, J. J. P., & Stroes, E. S. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176191.64314.07 · Cited by 106
Self-citationYu, R. Z., Geary, R. S., Flaim, J., Riley, G. C., Tribble, D. L., vanVliet, A. A., & Wedel, M. K. (2008) · Clinical Pharmacokinetics · doi:10.2165/0003088-200948010-00003 · Cited by 103
Low Plasma Cholesterol Levels Caused by a Short Deletion in the Apolipoprotein B Gene
Young, S. G., Northey, S. T., & McCarthy, B. J. (1988) · Science · doi:10.1126/science.3399894 · Cited by 93
Young, S. G., Bertics, S. J., Curtiss, L. K., Dubois, B. W., & Witztum, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113026 · Cited by 83
Illingworth, D. R. (1980) · Archives of Neurology · doi:10.1001/archneur.1980.00500590083015 · Cited by 76
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S. G., & Serlie, M. J. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2157-x · Cited by 75
Steinberg, D. I., Grundy, S. M., Mok, H. Y. I., Turner, J. D., Weinstein, D. B., Brown, W. V., & Albers, J. J. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109451 · Cited by 75
Familial homozygous hypobetalipoproteinemia
Cottrill, C. M., Glueck, C. J., Leuba, V., Millett, F., Puppione, D. L., & Brown, W. V. (1974) · Metabolism · doi:10.1016/0026-0495(74)90010-9 · Cited by 72
Ueshima, K., Akihisa-Umeno, H., Nagayoshi, A., Takakura, S., Matsuo, M., & Mutoh, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.247 · Cited by 66
Dullaart, R. P. F., Speelberg, B., Schuurman, H., Milne, R. W., Havekes, L. M., Marcel, Y. L., Geuze, H. J., Hulshof, M. M., & Erkelens, D. W. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112727 · Cited by 64
Shiomi, M., & Ito, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01419-4 · Cited by 61
Decreased Secretion of ApoB Follows Inhibition of ApoB−MTP Binding by a Novel Antagonist
Bakillah, A., Nayak, N., Saxena, U., Medford, R. M., & Hussain, M. M. (2000) · Biochemistry · doi:10.1021/bi9924009 · Cited by 58
Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy.
Hegele, R. A., & Ángel, A. (1985) · PubMed · Cited by 54
Homozygous Familial Hypercholesterolemia and Its Management
Marais, A. D., Firth, J. C., & Blom, D. J. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-822985 · Cited by 50
Intestinal and hepatic apolipoprotein B gene expression in abetalipoproteinemia
Black, D. D., Hay, R. V., Rohwer-Nutter, P., Ellinas, H., Stephens, J. K., Sherman, H. L., Teng, B.-B., Whitington, P. F., & Davidson, N. O. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90033-h · Cited by 50
Mullick, A. E., Fu, W., Graham, M. J., Lee, R. G., Witchell, D. R., Bell, T. A., Whipple, C. P., & Crooke, R. M. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011791 · Cited by 49
Hepatic peroxisomal abnormalities in abetalipoproteinemia
Collins, J. C., Scheinberg, I. H., Giblin, D. R., & Sternlieb, I. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90651-3 · Cited by 46
Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis
Buettner, R., Ottinger, I., Schölmerich, J., & Bollheimer, L. C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2003 · Cited by 46
Ethanol down‐regulates the transcription of microsomal triglyceride transfer protein gene
Lin, M. C.-M., Li, J. J., Wang, E., Princler, G. L., Kauffman, F. C., & Kung, H. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367349 · Cited by 39
Ridker, P. M., Kastelein, J. J. P., Genest, J. J., & Köenig, W. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht022 · Cited by 39
Self-citationTuteja, S., Duffy, D., Dunbar, R. L., Movva, R., Gadi, R., Bloedon, L. T., & Cuchel, M. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1351 · Cited by 36
Other Therapies for Reducing Low-Density Lipoprotein Cholesterol: Medications in Development
Stein, E. A. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.011 · Cited by 34
Lee, R. G., Fu, W., Graham, M. J., Mullick, A. E., Sipe, D., Gattis, D., Bell, T. A., Booten, S. L., & Crooke, R. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029215 · Cited by 33
Corte, C. D., Fintini, D., Giordano, U., Cappa, M., Brufani, C., Majo, F., Mennini, C., & Nobili, V. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04498.x · Cited by 32
Dhote, V. V., Joharapurkar, A. A., Kshirsagar, S. G., Dhanesha, N., PATEL, V. G., Patel, A., Raval, S., & Jain, M. R. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05513.x · Cited by 29
Furtado, J. D., Wedel, M. K., & Sacks, F. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p021717 · Cited by 24
Cardiovascular Therapeutic Applications
Crooke, R., Baker, B., & Wedel, M. (2007) · CRC Press eBooks · doi:10.1201/9780849387951-33 · Cited by 18
Cited by
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 773
Raal, F. J., Honarpour, N., Blom, D. J., Hovingh, G. K., Xu, F., Scott, R., Wasserman, S. M., & Stein, E. A. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61374-x · Cited by 734
Gidding, S. S., Ann Champagne, M., de Ferranti, S. D., Defesche, J., Ito, M. K., Knowles, J. W., McCrindle, B., Raal, F., Rader, D., Santos, R. D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000297 · Cited by 723
Self-citation
Metadata
- Authors
- Rader, D. J., & Kastelein, J. J. P.
- Venue
- Circulation
- Published
- 2014-03-04
- Volume
- 129
- Issue
- 9
- Pages
- 1022-1032
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2064387909
- Cited by
- 264
- References
- 80
- FWCI
- 35.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.